Endocrinology Medical News about bone turnover;endogenous Cushings syndrome

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bone turnover in patients with endogenous Cushings syndrome before and after successful treatment
Osteoporosis International, 06/17/09

Szappanos A et al. - Study demonstrates a correlations between serum cortisol and both bone formation and resorption markers in the active phase of Cushing’s syndrome (CS); osteocalcin (OC) may serve as a sensitive biologic marker of glucocorticoid activity in endogenous CS during its active phase and may reflect the clinical cure of the disease.

Methods

An investigation of:
- Time course of bone marker changes after the cure of CS, and
- Correlations between bone markers and serum cortisol concns
87 pts; followed up to 48 mo after surgical cure
Serum OC and collagen breakdown products (CTX) in pts were compared with that of 161 healthy controls

Results

OC showed a negative, while CTX displayed a positive correlation with serum cortisol
Pts with diabetes mellitus and myopathy had lower serum OC leve
Postoperative OC increased rapidly from the first few days or wks reaching its max at the sixth mo
It remained stable after the 24th postoperative mo

<< Previous
Catabolism of lipoproteins and metabolic syndrome

Next >>
Maternal Obesity and Breast-feeding Practices Among White and...

The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer
European Journal of Cancer, 10/23/09 Relevance Score: 69%

Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass
Osteoporosis International, 10/06/09 Relevance Score: 69%

Bone signaling pathways and treatment of osteoporosis
Expert Review of Endocrinology & Metabolism, 11/10/09 Relevance Score: 68%

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Therapeutics and Clinical Risk Management, 10/16/09 Relevance Score: 68%

The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial
Osteoporosis International, 10/06/09 Relevance Score: 68%